BioCardia's Upcoming Conference Call on Financial Results
BioCardia, Inc., a pioneer in cellular and cell-derived therapies, is set to provide key updates on its financial performance and developments within the company. The much-anticipated conference call will take place soon, specifically on November 12, 2025, at 4:30 PM EDT. This call will not only cover their financial results for the three and nine months concluded on September 30, 2025, but it will also include a question-and-answer segment where listeners can engage with management.
Registration Details for Participants
Individuals interested in participating in the conference call can easily register by visiting the company’s dedicated registration page. Registered participants will receive crucial details, including their dial-in numbers. Those who haven’t registered but wish to listen in can contact 1-833-316-0559 within the U.S., or 1-412-317-5730 for international calls. It is recommended that all callers log in about ten minutes early to ensure they don’t miss a moment of this informative session.
Accessing the Conference Call
For convenience, the conference will also be accessible via a live webcast. Interested parties can tune in through the provided link, where they can listen online. This format provides an alternative for those who prefer digital access from the comfort of their locations.
Replay of the Conference Call
Should you miss the live event, BioCardia has ensured that a replay will be available shortly after the call concludes. Both the webcast replay and the telephonic replay options will remain accessible for a period following the discussion. Whether you prefer to listen online or via phone, BioCardia is dedicated to making information available to all stakeholders.
About BioCardia
Headquartered in Sunnyvale, California, BioCardia, Inc. stands at the forefront of innovation in treating cardiovascular and pulmonary diseases through advanced cellular therapies. The company has developed notable platforms, including CardiAMP® for autologous therapies and CardiALLO™ for allogeneic treatments, both of which are integral to their clinical-stage product candidates. These innovative therapies are supported by the Helix™ biotherapeutic delivery system and Morph® vascular navigation tools, showcasing BioCardia’s commitment to advancing medical treatments. To explore more about their cutting-edge initiatives, visit their official website.
Frequently Asked Questions
What is the purpose of BioCardia's upcoming conference call?
The conference call aims to provide updates on BioCardia's financial results and ongoing developments in their therapeutic programs.
How can I participate in the conference call?
Participants can register through BioCardia’s official registration link to obtain the dial-in details for the call.
Will there be an opportunity for Q&A during the call?
Yes, after opening remarks, there will be a dedicated question-and-answer session for participants to engage with the management team.
What if I miss the live call?
A replay of the conference call will be available shortly after the event, allowing you to listen at your convenience.
Where can I find more information about BioCardia?
For more information regarding BioCardia’s projects and clinical advancements, you can visit their official website.